Publications by authors named "Kerry McMillen"

Article Synopsis
  • * Research involving younger patients with untreated AML (age ≤60) showed that class III obesity significantly increases early death rates and worsens overall survival compared to normal weight individuals.
  • * These results emphasize the need for more in-depth studies on the impacts of class III obesity in AML patients to better understand their unique risks and outcomes.
View Article and Find Full Text PDF
Article Synopsis
  • - The text discusses the relationship between obesity and outcomes in acute myeloid leukemia (AML), particularly focusing on how different obesity classes (I, II, and III) impact patient outcomes.
  • - A study involving younger AML patients (age ≤60) showed that class III obesity significantly increased the risk of early death and negatively affected overall survival compared to those with normal weight.
  • - The findings underscore the need for more research on the effects of class III obesity in AML patients to better understand their unique health risks.
View Article and Find Full Text PDF
Article Synopsis
  • - Oxaliplatin is a chemotherapy drug used to treat gastrointestinal cancers, but it can cause chemotherapy-induced peripheral neuropathy (CIPN), limiting treatment effectiveness.
  • - A pilot study is being conducted with 56 patients to investigate if acupuncture and acupressure can reduce CIPN and other chemotherapy-related side effects during treatment with 5-fluorouracil (5-FU) and oxaliplatin.
  • - Participants are randomly assigned to receive either acupuncture with self-acupressure or standard treatment, and various symptoms and side effects will be assessed over three months to evaluate the effectiveness and feasibility of this approach.
View Article and Find Full Text PDF

More information is needed about the impact of outpatient nutrition care from a registered dietitian nutritionist (RDN) on patient outcomes. This study aimed to assess the feasibility of a cohort study design to evaluate impact of RDN nutrition care on patient outcomes, describe clinic malnutrition screening practices, and estimate statistical parameters for a larger study. Seventy-seven patients with lung, esophageal, colon, rectal, or pancreatic cancer from six facilities were included (41 received RDN care and 36 did not).

View Article and Find Full Text PDF

Nutrition support is often required during hematopoietic cell transplant (HCT) given the gastrointestinal toxicity that frequently precludes adequate protein-calorie intake. This article reviews the latest evidence for enteral versus parenteral nutrition in the adult and pediatric HCT population and addresses key considerations as well as barriers to implement this in practice. Registered Dietitian Nutritionists are key members of the interdisciplinary team to proactively manage enteral nutrition support to provide timely, adequate protein and calories to help prevent malnutrition, loss of lean body mass, and functional decline as well as provide evidence-based diet recommendations.

View Article and Find Full Text PDF

Cancer patients and survivors are at risk of poor clinical outcomes due to poor nutritional intake following cancer diagnosis. During cancer treatment, treatment toxicities can affect eating patterns and can lead to malnutrition resulting in loss of lean body mass and excessive weight loss. Following treatment and throughout survivorship, patients are at risk of not meeting national nutrition guidelines for cancer survivors, which can affect recurrence and survival.

View Article and Find Full Text PDF

This retrospective analysis of 2503 adult (age ≥20 years) allogeneic hematopoietic cell transplantation (HCT) recipients assessed the effect of body mass index (BMI) on transplantation outcomes. The median patient age was 51.7years.

View Article and Find Full Text PDF

Diarrhea, abdominal pain, and fever are common among patients undergoing hematopoietic cell transplantation (HCT), but such symptoms are also typical with foodborne infections. The burden of disease caused by foodborne infections in patients undergoing HCT is unknown. We sought to describe bacterial foodborne infection incidence after transplantation within a single-center population of HCT recipients.

View Article and Find Full Text PDF

Background: Improved survival after allogeneic hematopoietic cell transplantation (allo-HCT) enables us to learn more about potential late complications after HCT, one of which is metabolic syndrome. There are no studies investigating the prevalence or development of metabolic syndrome within the first year post-HCT in adult myeloablative transplant recipients.

Methods: In this retrospective study, we evaluated the prevalence of and risk factors associated with metabolic syndrome early post-HCT in human subjects.

View Article and Find Full Text PDF